List of companies in DROIA Ventures's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Frontier Medicines is a biopharmaceutical company developing chemoproteomics for drug discovery founded in 2018. | ||||||
Hummingbird Bioscience is a clincal-stage biotechnology company. | ||||||
Vico Therapeutics is a medicine for rare neurological diseases founded in 2019. | ||||||
Muna develops transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases | ||||||
Accent Therapeutics is a RNA-modifying protein inhibitors founded in 2017 by Robert Copeland. | ||||||
Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins | ||||||
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases. | ||||||
Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases. | ||||||
Protein stabilization platform for cancer and genetic disorders | ||||||
Actio Biosciences is a biotechnology company pioneering precision medicine by developing genetically targeted therapies for both rare and common diseases. Leveraging advanced genomics, Actio aims to transform drug discovery through a patient-first, data-driven approach to therapeutic innovation. |
